Skip to content

Effect of small dose of nalmefene pretreatment on sufentanil-induced cough during general anesthesia induction: a randomized double-blind trial

Effect of small dose of nalmefene pretreatment on sufentanil-induced cough during general anesthesia induction: a randomized double-blind trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057284
Enrollment
Unknown
Registered
2022-03-06
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sufentanil-induced cough

Interventions

Group 3:nalmefene 0.2 ug/kg
Group 1 :no
Group 2:nalmefene 0.1 ug/kg

Sponsors

Peking University Shougang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic cholecystectomy; 2. Aged 18-65 years; 3. BMI 18-30 kg/m2; 4. ASA I-II.

Exclusion criteria

Exclusion criteria: 1. Refuse research; 2. Acute respiratory tract infection, chronic respiratory disease, long-term heavy smoking in the past two weeks; 3. Patients with a history of preoperative nausea and vomiting; 4. A history of mental illness or inability to communicate and cooperate; 5. Opioid abuse, allergic to opioids and nalmefene; 6. Insufficiency of liver and kidney function. Antidepressants or monoamine oxidase inhibitors were used 15 days before surgery; 7. Patients who need to be admitted to ICU for further treatment after surgery; 8. Patients undergoing surgical treatment due to bleeding at the surgical site within 24 hours after surgery; 9. Patients not scheduled to be transferred to ICU for further treatment.

Design outcomes

Primary

MeasureTime frame
classification of cough;

Secondary

MeasureTime frame
numerical rating scale score;blood pressure/mean arterial pressure;heart beats;nausea;vomiting;

Countries

China

Contacts

Public ContactAn Qi

Peking University Shougang Hospital

anqier19900212@hotmail.com+86 18330158210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026